Trademark: 85266326
Status Date
Monday, November 26, 2012
Filing Date
Monday, March 14, 2011
Published for Opposition
Tuesday, August 30, 2011
Abandoned Date
Monday, November 26, 2012
5 Human blood substitute containing a pharmaceutical preparation to provide super-accelerated oxygen delivery with ultra-fast onset, fluid-sparing and hematocrit-elevating properties to sustain the circulatory system and to accelerate healing of wounds
Nov 26, 2012
Abandonment Notice Mailed - No Use Statement Filed
Nov 26, 2012
Abandonment - No Use Statement Filed
May 31, 2012
Notice Of Approval Of Extension Request E-Mailed
May 30, 2012
Extension 1 Granted
Apr 25, 2012
Extension 1 Filed
May 30, 2012
Case Assigned To Intent To Use Paralegal
May 8, 2012
Notice Of Revival - E-Mailed
May 8, 2012
Extension Received With Teas Petition
May 8, 2012
Petition To Revive-Granted
May 8, 2012
Teas Petition To Revive Received
Oct 25, 2011
Noa E-Mailed - Sou Required From Applicant
Aug 30, 2011
Official Gazette Publication Confirmation E-Mailed
Aug 30, 2011
Published For Opposition
Jul 27, 2011
Law Office Publication Review Completed
Jul 19, 2011
Assigned To Lie
Jun 23, 2011
Approved For Pub - Principal Register
Jun 23, 2011
Examiner's Amendment Entered
Jun 23, 2011
Notification Of Examiners Amendment E-Mailed
Jun 23, 2011
Examiners Amendment E-Mailed
Jun 23, 2011
Examiners Amendment -Written
Jun 20, 2011
Notification Of Non-Final Action E-Mailed
Jun 20, 2011
Non-Final Action E-Mailed
Jun 20, 2011
Non-Final Action Written
Jun 13, 2011
Assigned To Examiner
Mar 19, 2011
Notice Of Pseudo Mark Mailed
Mar 18, 2011
New Application Office Supplied Data Entered In Tram
Mar 17, 2011
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
